Loss of ATRX promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin binding.
Bartholf DeWitt S, Hoskinson Plumlee S, Brighton HE, Sivaraj D, Martz EJ, Zand M, Kumar V, Sheth MU, Floyd W, Spruance JV, Hawkey N, Varghese S, Ruan J, Kirsch DG, Somarelli JA, Alman B, Eward WC.
Bartholf DeWitt S, et al. Among authors: eward wc.
JCI Insight. 2022 Sep 8;7(17):e151583. doi: 10.1172/jci.insight.151583.
JCI Insight. 2022.
PMID: 36073547
Free PMC article.